SSB
UTHR icon

Sandy Spring Bank’s United Therapeutics UTHR Stock Holding History

Sandy Spring Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-44
Closed -$4K – 960
2020
Q1 		$4K Hold
44
– – ﹤0.01% 786
2019
Q4 		$4K Hold
44
– – ﹤0.01% 787
2019
Q3 		$4K Hold
44
– – ﹤0.01% 801
2019
Q2 		$3K Buy
+44
New +$4.12K ﹤0.01% 802

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sandy Spring Bank's UTHR Position: Q2 2020 in Review

Sandy Spring Bank sold out of United Therapeutics (UTHR) in Q2 2020, closing a stake of 44 shares — an estimated $4K sold.

Sandy Spring Bank first reported a position in UTHR in Q2 2019 and held it in 4 quarters. The position peaked at $4K in Q1 2020. 349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

  • Sandy Spring Bank reported no remaining United Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Sandy Spring Bank sold 44 United Therapeutics shares in Q2 2020, an estimated $4K.
  • Sandy Spring Bank first reported a position in United Therapeutics in Q2 2019 and held it in 4 quarters.
  • Sandy Spring Bank's United Therapeutics position peaked at $4K in Q1 2020.
  • 349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on Sandy Spring Bank's 13F filing for Q2 2020, filed 12 Aug 2020.